ANTI-CD30

Clinical trials for ANTI-CD30 explained in plain language.

Never miss a new study

Get alerted when new ANTI-CD30 trials appear

Sign up with your email to follow new studies for ANTI-CD30, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo tested against standard treatment for blood cancer

Disease control Completed

This study compared two different chemotherapy combinations for people newly diagnosed with advanced Hodgkin lymphoma. Researchers tested whether replacing one drug (bleomycin) with a targeted medication (brentuximab vedotin) would work as well or better while potentially causing…

Matched conditions: ANTI-CD30

Phase: NA • Sponsor: Helwan University • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

ANTI-CD30

Get alerted when new ANTI-CD30 trials appear

New drug combo tested against standard treatment for blood cancer